UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
UNH$407.46+0.6%Stored close · as of Nov 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Equity
Checking your notes…
| Common Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive (Loss) Income · NonredeemableNoncontrolling Interests · TotalEquity | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions, except per share data) · Shares · Amount · Net Unrealized (Losses) Gains on Investments · Foreign Currency Translation (Losses) Gains | ||||||||||||||
| Balance at January 1, 2023 | 934 | $9 | $— | $86,156 | $(2,778) | $(5,615) | $3,678 | $81,450 | ||||||
| Net earnings | 22,381 | 575 | 22,956 | |||||||||||
| Other comprehensive income | 807 | 559 | 1,366 | |||||||||||
| Issuances of common stock, and related tax effects | 6 | — | 1,231 | 1,231 | ||||||||||
| Share-based compensation | 1,027 | 1,027 | ||||||||||||
| Common share repurchases | (16) | — | (2,057) | (6,002) | (8,059) | |||||||||
| Cash dividends paid on common shares ($7.29 per share) | (6,761) | (6,761) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (201) | (201) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 1,928 | 1,928 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (516) | (516) | ||||||||||||
| Balance at December 31, 2023 | 924 | 9 | — | 95,774 | (1,971) | (5,056) | 5,665 | 94,421 | ||||||
| Net earnings | 14,405 | 663 | 15,068 | |||||||||||
| Other comprehensive (loss) income | (255) | 3,895 | 3,640 | |||||||||||
| Issuances of common stock, and related tax effects | 8 | — | 1,485 | 1,485 | ||||||||||
| Share-based compensation | 963 | 963 | ||||||||||||
| Common share repurchases | (17) | — | (2,395) | (6,610) | (9,005) | |||||||||
| Cash dividends paid on common shares ($8.18 per share) | (7,533) | (7,533) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (53) | (53) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 26 | 26 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (744) | (744) | ||||||||||||
| Balance at December 31, 2024 | 915 | 9 | — | 96,036 | (2,226) | (1,161) | 5,610 | 98,268 | ||||||
| Net earnings | 12,056 | 677 | 12,733 | |||||||||||
| Other comprehensive income | 1,148 | 178 | 1,326 | |||||||||||
| Issuances of common stock, and related tax effects | 3 | — | 649 | 649 | ||||||||||
| Share-based compensation | 979 | 979 | ||||||||||||
| Common share repurchases | (12) | — | (952) | (4,573) | (5,525) | |||||||||
| Cash dividends paid on common shares ($8.73 per share) | (7,916) | (7,916) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (117) | (117) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 390 | 390 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (697) | (697) | ||||||||||||
| Balance at December 31, 2025 | 906 | $9 | $559 | $95,603 | $(1,078) | $(983) | $5,980 | $100,090 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.